Standout Papers
Citation Impact
Citing Papers
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
2014
Identification of a Polycystic Ovary Syndrome Susceptibility Variant in Fibrillin-3 and Association with a Metabolic Phenotype
2007
Overweight, obesity, and cancer risk
2002
An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials
2015
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
2006
Children's Hospital Association Consensus Statements for Comorbidities of Childhood Obesity
2014
Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents
2015
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
2016
Nonclassic Congenital Adrenal Hyperplasia
2010
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
Sheep models of polycystic ovary syndrome phenotype
2012
Hormonal Effects of Flutamide in Young Women with Polycystic Ovary Syndrome
1998
Development of polycystic ovary syndrome: involvement of genetic and environmental factors
2005
Epithelial Ovarian Cancer Risk Among Women With Polycystic Ovary Syndrome
1996
Putative Activation of the Peroxisome Proliferator-Activated Receptor γ Impairs Androgen and Enhances Progesterone Biosynthesis in Primary Cultures of Porcine Theca Cells1
2002
Abdominal adiposity and the polycystic ovary syndrome
2007
What every physician should know about polycystic ovary syndrome
2008
Detection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess
1992
Estrogen receptors and human disease
2006 Standout
Hyperandrogenemia in Obese Peripubertal Girls: Correlates and Potential Etiological Determinants
2010
Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome
2007
Acne Vulgaris
2002
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
2008
Global health burden and needs of transgender populations: a review
2016 Standout
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome
2017
Family-based analysis of eight susceptibility loci in polycystic ovary syndrome
2015
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
2010
Follicle dynamics and anovulation in polycystic ovary syndrome
2008
Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis
2009
Drospirenone/Ethinyl EstradiolVersusRosiglitazone Treatment in Overweight Adolescents with Polycystic Ovary Syndrome: Comparison of Metabolic, Hormonal, and Cardiovascular Risk Factors
2011
Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria
2007
Prevalence of ‘obesity-associated gonadal dysfunction’ in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis
2017
Reproductive outcome after bariatric surgery: a critical review
2008
Luteinizing Hormone Receptor, Steroidogenesis Acute Regulatory Protein, and Steroidogenic Enzyme Messenger Ribonucleic Acids Are Overexpressed in Thecal and Granulosa Cells from Polycystic Ovaries1
2001
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
2017
Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome
2014
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk
2012
Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response
2008
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Post-transcriptional gene regulation by mRNA modifications
2016 Standout
Augmented Androgen Production Is a Stable Steroidogenic Phenotype of Propagated Theca Cells from Polycystic Ovaries
1999
Polycystic ovary syndrome after precocious pubarche: ontogeny of the low‐birthweight effect
2001
The adrenal and polycystic ovary syndrome
2007
Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women
1998
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity
2004
Gonadotrophin and gonadal steroid response to a single dose of a long‐acting agonist of gonadotrophin‐releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome
1995
Dermatology of androgen-related disorders
2006
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase
2001
Diagnosis and treatment of polycystic ovarian syndrome in adolescents
2012
Adult polycystic ovary syndrome begins in childhood
2002
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
1995
Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
2001
Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome
2008
The Molecular Signatures Database Hallmark Gene Set Collection
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Insulin Resistance, Premature Adrenarche, and a Risk of the Polycystic Ovary Syndrome (PCOS)
1998
Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity
2015
The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
2009
Sexual dimorphism of body composition
2007
Does PCOS have developmental origins?
2011
Do hyperandrogenic women with normal menses have polycystic ovary syndrome?
1999
Prevalence and Trends in Obesity Among US Adults, 1999-2008
2010 Standout
The medical complications of obesity
2006
Effects of Metformin on Insulin Secretion, Insulin Action, and Ovarian Steroidogenesis in Women with Polycystic Ovary Syndrome1
1997
The genetics of the polycystic ovary syndrome
2007
Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: A Mendelian randomization meta-analysis
2009
Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 Standout
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
2001
Neuromodulation in Polycystic Ovary Syndrome
2001
Genetic Variations in Calpain-10 Gene Are Not a Major Factor in the Occurrence of Type 2 Diabetes in Japanese
2003
The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis
2003
Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome
2011
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
2006 Standout
Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
2006
Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization
2002
Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
2010 Standout
Aberrant Expression of Growth Differentiation Factor-9 in Oocytes of Women with Polycystic Ovary Syndrome
2002
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Tissue specificity: the clinical importance of steroid metabolites in hormone replacement therapy
2001
Formation of Cystic Ovarian Follicles Associated with Elevated Luteinizing Hormone Requires Estrogen Receptor-β
2004
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis
2015
Women's experiences of polycystic ovary syndrome diagnosis
2014
Intractable Early Childhood Obesity as the Initial Sign of Insulin Resistant Hyperinsulinism and Precursor of Polycystic Ovary Syndrome
2007
Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome
2010
Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome
2008
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study
2010
Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome
2002
Polycystic ovary syndrome and its developmental origins
2007
Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial
2002
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
2014
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Effects of Race and Family History of Type 2 Diabetes on Metabolic Status of Women with Polycystic Ovary Syndrome
2005
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The Roles of Insulin Sensitivity, Insulin-Like Growth Factor I (IGF-I), and IGF-Binding Protein-1 and -3 in the Hyperandrogenism of African-American and Caribbean Hispanic Girls with Premature Adrenarche1
1999
Polycystic Ovary Syndrome
1995 Standout
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
2006
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
2005
Intra-follicular activin availability is altered in prenatally-androgenized lambs
2001
High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome
2010
Functional genomics of PCOS: from GWAS to molecular mechanisms
2015
Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1
1997
Searching for polycystic ovary syndrome in postmenopausal women
2007
Endocrine Antecedents of Polycystic Ovary Syndrome in Fetal and Infant Prenatally Androgenized Female Rhesus Monkeys1
2008
Heritability of Polycystic Ovary Syndrome in a Dutch Twin-Family Study
2006
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
1993
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Acne vulgaris
2011 Standout
Insights into the Development of Polycystic Ovary Syndrome (PCOS) from Studies of Prenatally Androgenized Female Rhesus Monkeys
1998
POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE
1989
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
2011
Reproductive endocrinology of adolescent polycystic ovary syndrome
2009
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome
2011
Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome
2016
The genetic basis of polycystic ovary syndrome
1997
Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
1996
Enzymatic Activities of P450c17 Stably Expressed in Fibroblasts from Patients with the Polycystic Ovary Syndrome1
2000
Dynamics of bioactive follicle-stimulating hormone secretion in women with polycystic ovary syndrome: effects of estradiol and progesterone
2001
Fetal growth, length of gestation, and polycystic ovaries in adult life
1997
Diagnosis of Polycystic Ovarian Syndrome: In Defense of the Rotterdam Criteria
2006
Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies
2006
Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women
2014
Inflammatory and endothelial markers in women with polycystic ovary syndrome
2006
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance
2015
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome
2006
Pregnancy complications in women with polycystic ovary syndrome
2015
Subclinical Thyroid Disease
2004 Standout
Insulin and insulin resistance:
2004 Standout
Hyperinsulinaemic androgen excess in adolescent girls
2014
Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system
1998
Developmental origin of polycystic ovary syndrome - a hypothesis
2002
Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS
2007
The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
2015
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
2016
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Clinical spectrum of premature pubarche: Links to metabolic syndrome and ovarian hyperandrogenism
2008
Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population
2006
The investigation and management of hirsutism
2012
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
2005
The Use and Limitations of a Chemiluminescent Thyrotropin Assay as a Single Thyroid Function Test in an Out-Patient Endocrine Clinic*
1990
Twenty years of endocrinologic treatment in transsexualism: analyzing the role of chromosomal analysis and hormonal profiling in the diagnostic work-up
2013
Lifestyle changes in women with polycystic ovary syndrome
2011
Androgen excess: Investigations and management
2016
The Metabolic Syndrome in Polycystic Ovary Syndrome
2007
Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal
2008
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
2009 Standout
Production and Actions of Estrogens
2002 Standout
Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause
2013
Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: From a complex constellation to a simple sequence of prenatal onset
1998
Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test
2011
A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open‐label parallel study
2008
The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance
2008
Polycystic ovary syndrome and environmental toxins
2016
Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity
2010
Identifying Children at Risk for Polycystic Ovary Syndrome
2006
Hyperinsulinemia Amplifies GnRH Agonist Stimulated Ovarian Steroid Secretion in Women with Polycystic Ovary Syndrome
2012
Polycystic ovary syndrome
2016 Standout
Polycystic ovary syndrome in adolescents
2008
Use of a Gonadotropin-Releasing Hormone Antagonist as a Physiologic Probe in Polycystic Ovary Syndrome: Assessment of Neuroendocrine and Androgen Dynamics1
1998
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries
2012
MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
2014
Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
2017
Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS
2010
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Prenatal Androgen Treatment Alters Body Composition and Glucose Homeostasis in Male Rats
2010
Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
2002
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Obesity and infertility
2007
Polycystic ovary syndrome in bulimic women – an evaluation based on the new diagnostic criteria
2006
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys
2009
Birth weight in offspring of mothers with polycystic ovarian syndrome
2005
Shared decision making in endocrinology: present and future directions
2016
Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case–control study and meta-analysis
2012
Anatomical evidence for in utero androgen exposure in women with polycystic ovary syndrome
2005
Visually scoring hirsutism
2009
Current Concepts in the Polycystic Ovary Syndrome
2001
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Obese Patients with Polycystic Ovary Syndrome: Evidence that Metformin Does Not Restore Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Ovarian Steroids
2003
Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary Syndrome
2009
Phenotype and genotype in polycystic ovary syndrome
2001
Are Young Adult Women With Polycystic Ovary Syndrome Slipping Through the Healthcare Cracks?
2014
Associations of Birthweight and Gestational Age with Reproductive and Metabolic Phenotypes in Women with Polycystic Ovarian Syndrome and Their First-Degree Relatives
2009
Obesity Is the Major Determinant of the Abnormalities in Blood Pressure Found in Young Women with the Polycystic Ovary Syndrome
2007
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects
2016
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial
2017
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Polycystic Ovarian Syndrome: Long-Term Health Consequences
2017
Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
2014
Prevalence and follow‐up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom
1991
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999
Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome
1991
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
2005
Increased Prevalence of Gestational Diabetes Mellitus Among Women With Diagnosed Polycystic Ovary Syndrome
2006
Functional Significance of Polycystic-Size Ovaries in Healthy Adolescents
2006
Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up
2006
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
1996
Normal Ovulatory Women with Polycystic Ovaries Have Hyperandrogenic Pituitary-Ovarian Responses To Gonadotropin-Releasing Hormone-Agonist Testing*
2000
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Human Fetal Ovary Development Involves the Spatiotemporal Expression of P450c17 Protein
2006
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
1998
Lifestyle changes in women with polycystic ovary syndrome
2011
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Asymptomatic Volunteers with a Polycystic Ovary Are a Functionally Distinct but Heterogeneous Population
2009
Family-Based Analysis of Candidate Genes for Polycystic Ovary Syndrome
2010
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Effect of Lifestyle Intervention on Features of Polycystic Ovarian Syndrome, Metabolic Syndrome, and Intima-Media Thickness in Obese Adolescent Girls
2011
Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome
2002
Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
1995
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Heritability of Insulin Secretion and Insulin Action in Women with Polycystic Ovary Syndrome and Their First Degree Relatives1
2001
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Linkage of regulators of TGF‐β activity in the fetal ovary to polycystic ovary syndrome
2011
Insulin and insulin resistance.
2005
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
2006
Impaired Insulin Activation and Dephosphorylation of Glycogen Synthase in Skeletal Muscle of Women with Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
2008
Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome
2007
Early origins of polycystic ovary syndrome
2005
Premature Adrenarche—Normal Variant or Forerunner of Adult Disease?*
2000
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
2012
Approach to the Patient: Contraception in Women With Polycystic Ovary Syndrome
2015
Fine Mapping of Genetic Susceptibility to Polycystic Ovary Syndrome on Chromosome 19p13.2 and Tests for Regulatory Activity
2006
Drug treatments for polycystic ovary syndrome.
2009
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
2003
Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome
2009
American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
2015
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
2015
Metformin Therapy in Obese Adolescents with Polycystic Ovary Syndrome and Impaired Glucose Tolerance: Amelioration of Exaggerated Adrenal Response to Adrenocorticotropin with Reduction of Insulinemia/Insulin Resistance
2002
Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome
2007
Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome
1990
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Resistance of Gonadotropin Releasing Hormone Drive to Sex Steroid-Induced Suppression in Hyperandrogenic Anovulation1
1997
The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome
2001
Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
2016 Standout
Pathways Leading to Phosphorylation of P450c17 and to the Posttranslational Regulation of Androgen Biosynthesis
2008
High Prevalence of Metabolic Syndrome in First-Degree Male Relatives of Women with Polycystic Ovary Syndrome Is Related to High Rates of Obesity
2009
Infants of Women with Polycystic Ovary Syndrome Have Lower Cord Blood Androstenedione and Estradiol Levels
2010
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Insulin as an Effector of Human Ovarian and Adrenal Steroid Metabolism
1991
Environmental Factors and Puberty Timing: Expert Panel Research Needs
2008
Assessment of Child and Adolescent Overweight and Obesity
2007
The Androgen Receptor in Health and Disease
2012
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Endocrine and Metabolic Effects of Rosiglitazone in Non-obese Women with Polycystic Ovary Disease
2005
FTOGene Variants Are Associated with PCOS Susceptibility and Hyperandrogenemia in Young Korean Women
2014
Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
2007
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
2000 StandoutScience
Hyperinsulinemia and Decreased Insulin-Like Growth Factor-Binding Protein-1 Are Common Features in Prepubertal and Pubertal Girls with a History of Premature Pubarche1
1997
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of David A. Ehrmann being referenced
INSULIN-LOWERING THERAPEUTIC MODALITIES FOR POLYCYSTIC OVARY SYNDROME
1999
Pituitary-Ovarian Responses to Nafarelin Testing in the Polycystic Ovary Syndrome
1989
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Gonadotropin‐Releasing Hormone Agonist as a Probe for the Pathogenesis and Diagnosis of Ovarian Hyperandrogenism
1993
Polycystic Ovary Syndrome
2005 Standout
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
1995
Relationship of Calpain-10 Genotype to Phenotypic Features of Polycystic Ovary Syndrome
2002
Detection of Functional Ovarian Hyperandrogenism in Women With Androgen Excess
1993
Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
1994
Limitations to the Use of a Sensitive Assay for Serum Thyrotropin in the Assessment of Thyroid Status
1989